A detailed history of Janus Henderson Group PLC transactions in Baxter International Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 1,173,932 shares of BAX stock, worth $39.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,173,932
Previous 1,794,361 34.58%
Holding current value
$39.3 Million
Previous $69.4 Million 27.67%
% of portfolio
0.03%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$37.88 - $43.77 $23.5 Million - $27.2 Million
-620,429 Reduced 34.58%
1,173,932 $50.2 Million
Q4 2023

Feb 14, 2024

SELL
$31.71 - $38.95 $3.06 Million - $3.76 Million
-96,523 Reduced 5.1%
1,794,361 $69.4 Million
Q3 2023

Nov 14, 2023

SELL
$37.32 - $49.29 $1.32 Million - $1.74 Million
-35,278 Reduced 1.83%
1,890,884 $71.4 Million
Q2 2023

Aug 14, 2023

BUY
$39.98 - $47.68 $73.9 Million - $88.1 Million
1,848,597 Added 2383.29%
1,926,162 $87.8 Million
Q1 2023

May 15, 2023

SELL
$37.58 - $52.57 $5.41 Million - $7.57 Million
-144,049 Reduced 65.0%
77,565 $3.15 Million
Q4 2022

Feb 14, 2023

BUY
$49.7 - $57.71 $8.19 Million - $9.51 Million
164,716 Added 289.49%
221,614 $11.3 Million
Q3 2022

Nov 14, 2022

SELL
$53.86 - $66.8 $133,034 - $164,996
-2,470 Reduced 4.16%
56,898 $3.07 Million
Q2 2022

Aug 15, 2022

SELL
$63.83 - $80.0 $9.66 Million - $12.1 Million
-151,264 Reduced 71.81%
59,368 $3.81 Million
Q1 2022

May 16, 2022

BUY
$76.85 - $89.45 $6.28 Million - $7.31 Million
81,689 Added 63.35%
210,632 $16.3 Million
Q4 2021

Feb 14, 2022

SELL
$74.57 - $87.19 $19.9 Million - $23.3 Million
-267,410 Reduced 67.47%
128,943 $11.1 Million
Q3 2021

Nov 16, 2021

SELL
$73.77 - $83.61 $59.3 Million - $67.3 Million
-804,489 Reduced 66.99%
396,353 $31.9 Million
Q2 2021

Aug 16, 2021

SELL
$80.5 - $88.01 $19 Million - $20.8 Million
-235,783 Reduced 16.41%
1,200,842 $96.7 Million
Q1 2021

May 17, 2021

SELL
$76.38 - $86.03 $26.6 Million - $29.9 Million
-347,945 Reduced 19.5%
1,436,625 $121 Million
Q4 2020

Feb 16, 2021

SELL
$75.39 - $82.36 $9.63 Million - $10.5 Million
-127,722 Reduced 6.68%
1,784,570 $143 Million
Q3 2020

Nov 16, 2020

SELL
$78.33 - $90.73 $1.85 Million - $2.14 Million
-23,613 Reduced 1.22%
1,912,292 $154 Million
Q2 2020

Aug 14, 2020

SELL
$78.66 - $94.14 $19.2 Million - $22.9 Million
-243,630 Reduced 11.18%
1,935,905 $167 Million
Q1 2020

May 14, 2020

SELL
$71.57 - $93.3 $33 Million - $43 Million
-461,284 Reduced 17.47%
2,179,535 $177 Million
Q4 2019

Feb 18, 2020

SELL
$76.7 - $88.45 $58.6 Million - $67.6 Million
-764,464 Reduced 22.45%
2,640,819 $221 Million
Q3 2019

Nov 14, 2019

SELL
$81.4 - $89.78 $60.9 Million - $67.2 Million
-748,663 Reduced 18.02%
3,405,283 $298 Million
Q2 2019

Jul 31, 2019

SELL
$73.44 - $82.41 $13.8 Million - $15.4 Million
-187,313 Reduced 4.31%
4,153,946 $340 Million
Q1 2019

Apr 30, 2019

SELL
$64.48 - $81.31 $30.6 Million - $38.6 Million
-475,306 Reduced 9.87%
4,341,259 $353 Million
Q4 2018

Feb 06, 2019

BUY
$61.45 - $77.8 $30.4 Million - $38.5 Million
495,440 Added 11.47%
4,816,565 $317 Million
Q3 2018

Nov 09, 2018

BUY
$70.71 - $77.75 $21.7 Million - $23.8 Million
306,714 Added 7.64%
4,321,125 $333 Million
Q2 2018

Aug 10, 2018

SELL
$63.43 - $75.41 $10.3 Million - $12.2 Million
-162,129 Reduced 3.88%
4,014,411 $296 Million
Q1 2018

May 14, 2018

SELL
$62.56 - $72.26 $3.6 Million - $4.16 Million
-57,577 Reduced 1.36%
4,176,540 $272 Million
Q4 2017

Feb 09, 2018

BUY
$61.45 - $66.05 $21.9 Million - $23.5 Million
356,228 Added 9.19%
4,234,117 $274 Million
Q3 2017

Nov 14, 2017

BUY
$59.5 - $64.61 $35 Million - $38 Million
588,487 Added 17.89%
3,877,889 $0
Q2 2017

Aug 17, 2017

BUY
N/A
3,289,402
3,289,402 $199 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.9B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.